Image Description (Fig1)
This appears to be a figure related to a study or clinical trial, showing data on the progression-free survival of patients using two different treatments (Imatinib Mesylate and IFN+Arc-C). The figure includes a graph indicating the progression-free survival of the treatments over time, with the number of patients and hazard ratios also provided. The data is presented as months since randomization.*